Manufacturer:

Eisai

Name:

HALAVEN

Category:

J Code

HCPCS:

J9179

NDC(s):

62856-0389-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

HALAVEN is a Cancer drug manufactured by Eisai and administered via the Intravenous route of administration. The J Code: J9179 is aligned to the drug HALAVEN.